|Description||Bradanicline hydrochloride is Alpha-7 Nicotinic Receptor Agonist. It showed cognitive enhancing effects in animal studies, and was being developed as a potential treatment for schizophrenia and attention deficit disorder. It was discontinued for Alzheimer's disease and cognitive impairment in schizophrenia in late 2013. It was also discontinued for ADHD, and no longer seems to be being developed.|
|Solubility||10 mM in DMSO|
|Application||Bradanicline hydrochloride was being developed as a potential treatment for schizophrenia and attention deficit disorder.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
Nelonicline is an Alpha7 nicotinic acetylcholine receptor(nAChR) agonist and Nicotinic acetylcholine receptor agonist. It plays a key role in inflammatory proce...
UB 165 fumarate
UB 165 fumarate is a full agonist at α3β2- and a weak partial agonist at α4β2- containing nAChRs (Ki = 0.27, 20 (IC50), 2790 and 990 nM for α4β2, α3, α7 and α1β...
4-Acetyl-1,1-dimethylpiperazinium iodide is a structural analog of acetylcholine, which is a nicotinic (AChR) agonist with Ki value of 29.9 nM at α4β2.
SIB 1553A hydrochloride
SIB 1553A hydrochloride is a nicotinic acetylcholine receptor (nAChR) agonist with selectivity for β4 subunit-containing receptors. It stimulates acetylcholine ...
DMAB-anabaseine dihydrochloride is a partial agonist at α7-containing neuronal nicotinic receptors and antagonist at α4β2 and other nicotinic receptors. It pote...
AR-R 17779 hydrochloride
AR-R17779 has been found to be a selective alpha7 nicotinic agonist and could probably reduce blood pressure and serum lipid levels.
PG-9 maleate, derived from (+)-R-hyoscyamine, is a potent analgesic and nootropic agent, which increases release of acetylcholine.